Dr. Jeremy D. Rudnick
Claim this profileCedars-Sinai Medical Center
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
26 drugs studied
Area of expertise
1Brain Tumor
Stage IV
TMB
EGFR
2Glioblastoma
TMB
EGFR
+7/-10
Affiliated Hospitals
Clinical Trials Jeremy D. Rudnick is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Keto Diet vs Standard Cancer Diet
for Glioblastoma
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be randomized 1:1 to receive Keto Diet, or Standard Anti-Cancer Diet. All patients will receive standard of care treatment for their glioblastoma. The Keto Diet intervention will be for an 18-week period and conducted by trained research dietitians. Daily ketone and glucose levels will be recorded to monitor Keto Diet adherence. This two-armed randomized multi-site study aims to provide evidence to support the hypothesis that a Keto Diet vs. Standard Anti-Cancer Diet improves overall survival in newly diagnosed glioblastoma multiforme patients who receive standard of care treatment.
Recruiting0 awards Phase 2
More about Jeremy D. Rudnick
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Jeremy D. Rudnick has experience with
- Nivolumab
- Stereotactic Radiation Therapy
- Pembrolizumab
- Ipilimumab
- Abemaciclib
- APL-101
Breakdown of trials Jeremy D. Rudnick has run
Brain Tumor
Glioblastoma
Cancer
MET Fusion
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy D. Rudnick specialize in?
Jeremy D. Rudnick focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are TMB.
Is Jeremy D. Rudnick currently recruiting for clinical trials?
Yes, Jeremy D. Rudnick is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jeremy D. Rudnick has studied deeply?
Yes, Jeremy D. Rudnick has studied treatments such as Nivolumab, Stereotactic Radiation Therapy, Pembrolizumab.
What is the best way to schedule an appointment with Jeremy D. Rudnick?
Apply for one of the trials that Jeremy D. Rudnick is conducting.
What is the office address of Jeremy D. Rudnick?
The office of Jeremy D. Rudnick is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.